Data / Form D filings / Immune Design Corp.
Immune Design Corp.: Form D filings
Immune Design Corp., a biotechnology company in Seattle, WA, filed 11 Form D notices with the SEC between 2009 and 2014. The latest, on June 12, 2014, reports $17,500 sold of a $17,500 offering to 1 investor.
Find out what Immune Design Corp. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1616 EASTLAKE AVE. E, SUITE 310, Seattle, WA, 98102
- Phone
- (206) 682-0645
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1437786
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 12, 2014 | New notice | $17,500 | $17,500 | $0 | 1 | Mar 10, 2011 | sec.gov |
| Jun 11, 2014 | New notice | $10 | $10 | $0 | 1 | Feb 20, 2008 | sec.gov |
| Jun 11, 2014 | Amendment | $10,500 | $10,500 | $0 | 1 | Jul 21, 2010 | sec.gov |
| Oct 31, 2013 | New notice | $57,750,000 | $48,450,000 | $9,300,000 | 8 | Oct 16, 2013 | sec.gov |
| Jan 30, 2013 | Amendment | $34,000,000 | $34,000,000 | $0 | 6 | Jul 23, 2010 | sec.gov |
| Oct 5, 2011 | Amendment | $34,000,000 | $23,374,992 | $10,625,008 | 6 | Jul 23, 2010 | sec.gov |
| Aug 26, 2010 | Amendment | $34,000,000 | $12,749,996 | $21,250,004 | 6 | Jul 23, 2010 | sec.gov |
| Aug 5, 2010 | New notice | $32,000,000 | $12,000,000 | $20,000,000 | 5 | Jul 23, 2010 | sec.gov |
| Oct 6, 2009 | New notice | $10,500 | $10,500 | $0 | 1 | Sep 22, 2009 | sec.gov |
| Jul 29, 2009 | New notice | $14,000 | $14,000 | $0 | 1 | Jul 16, 2009 | sec.gov |
| Jul 8, 2009 | Amendment | $18,000,000 | $14,000,000 | $4,000,000 | 4 | Jun 5, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul T. Rickey | Executive Officer | |
| Wayne R. Gombotz | Executive Officer | |
| Franklin T. Berger | Director | |
| David V. Baltimore | Director | |
| Ed V. Penhoet | Director | |
| Stephen R. Brady | Executive Officer | |
| Carlos V. Paya | Executive Officer, Director | |
| Richard T. Kenney | Executive Officer | |
| Brian V. Atwood | Director | |
| Jan Henrik T. ter Meulen | Executive Officer | |
| William T. Ringo | Director | |
| Peter V. Svennilson | Director |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Jun 9, 2014 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Immune Design Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.